tiprankstipranks
Tempest Therapeutics (TPST)
NASDAQ:TPST
Holding TPST?
Track your performance easily

Tempest Therapeutics (TPST) Financial Statements

1,133 Followers

Tempest Therapeutics Financial Overview

Tempest Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.536; its P/E ratio is -0.62; Tempest Therapeutics is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -10.56M$ -9.20M$ -7.54M$ -6.41M$ -7.23M
EBITDA$ -10.46M$ -9.04M$ -7.45M$ -6.33M$ -7.14M
Net Income Common Stockholders$ -10.56M$ -9.57M$ -7.90M$ -6.79M$ -7.58M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 22.10M$ 31.10M$ 32.30M$ 11.10M$ 17.60M
Total Assets$ 33.84M$ 42.17M$ 44.38M$ 23.99M$ 30.74M
Total Debt$ 17.74M$ 20.25M$ 20.37M$ 21.01M$ 21.48M
Net Debt$ -4.36M$ -10.85M$ -11.93M$ 9.91M$ 3.88M
Total Liabilities$ 22.38M$ 25.23M$ 23.75M$ 25.18M$ 25.73M
Stockholders Equity$ 11.46M$ 16.94M$ 20.63M$ -1.19M$ 5.01M
Cash Flow-
Free Cash Flow$ -10.20M$ -5.76M$ -7.35M$ -6.49M$ -6.51M
Operating Cash Flow$ -10.18M$ -5.51M$ -7.19M$ -6.49M$ -6.39M
Investing Cash Flow$ -15.00K$ -249.00K$ -168.00K-$ -117.00K
Financing Cash Flow$ 1.54M$ 4.56M$ 450.00K$ 21.00K$ 1.19M
Currency in USD

Tempest Therapeutics Earnings and Revenue History

Tempest Therapeutics Debt to Assets

Tempest Therapeutics Cash Flow

Tempest Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis